BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gando S, Wada T. Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies. Front Immunol 2021;12:649122. [PMID: 34177896 DOI: 10.3389/fimmu.2021.649122] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
Number Citing Articles
1 Seo J, Kim D, Yun N, Kim D. Coronavirus Disease 2019-Associated Coagulopathy. Microorganisms 2022;10:1556. [DOI: 10.3390/microorganisms10081556] [Reference Citation Analysis]
2 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Niedźwiedzka-Rystwej P, Majchrzak A, Kurkowska S, Małkowska P, Sierawska O, Hrynkiewicz R, Parczewski M. Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm. Int J Mol Sci 2022;23:4545. [PMID: 35562935 DOI: 10.3390/ijms23094545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zhang Q, Ling S, Hu K, Liu J, Xu J. Role of the renin-angiotensin system in NETosis in the coronavirus disease 2019 (COVID-19). Biomedicine & Pharmacotherapy 2022;148:112718. [DOI: 10.1016/j.biopha.2022.112718] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Panther EJ, Lucke-Wold B. Subarachnoid hemorrhage: management considerations for COVID-19. Explor Neuroprotective Ther 2022;2:65-73. [PMID: 35340712 DOI: 10.37349/ent.2022.00018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Takauji S, Tanaka H, Hayakawa M, Horioka K, Isozaki S, Konishi H. Soluble thrombomodulin ameliorates aberrant hemostasis after rewarming in a rat accidental hypothermia model. Biochem Biophys Res Commun 2022;587:1-8. [PMID: 34856423 DOI: 10.1016/j.bbrc.2021.11.086] [Reference Citation Analysis]
7 Bosch-Barrera J, Roqué A, Teixidor E, Carmona-Garcia MC, Arbusà A, Brunet J, Martin-Castillo B, Cuyàs E, Verdura S, Menendez JA. Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin. Pharmaceuticals (Basel) 2021;15:19. [PMID: 35056076 DOI: 10.3390/ph15010019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Rochette L, Zeller M, Cottin Y, Vergely C. GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism. Trends Endocrinol Metab 2021;32:875-89. [PMID: 34593305 DOI: 10.1016/j.tem.2021.08.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yamamoto N, Nishida N, Yamamoto R, Gojobori T, Shimotohno K, Mizokami M, Ariumi Y. Angiotensin-Converting Enzyme (ACE) 1 Gene Polymorphism and Phenotypic Expression of COVID-19 Symptoms. Genes (Basel) 2021;12:1572. [PMID: 34680966 DOI: 10.3390/genes12101572] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
10 Mangge H, Kneihsl M, Schnedl W, Sendlhofer G, Curcio F, Domenis R. Immune Responses against SARS-CoV-2-Questions and Experiences. Biomedicines 2021;9:1342. [PMID: 34680460 DOI: 10.3390/biomedicines9101342] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
11 Kaklamanos A, Belogiannis K, Skendros P, Gorgoulis VG, Vlachoyiannopoulos PG, Tzioufas AG. COVID-19 Immunobiology: Lessons Learned, New Questions Arise. Front Immunol 2021;12:719023. [PMID: 34512643 DOI: 10.3389/fimmu.2021.719023] [Cited by in F6Publishing: 4] [Reference Citation Analysis]